Form 4: GoodRx Holdings Executive Scott Wagner Reports Stock Transactions
SEC Form 4 Filing
Scott Wagner, Interim CEO of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.
Summary
- On July 8, 2024, Scott Wagner, Interim CEO of GoodRx Holdings, reported transactions involving Class A Common Stock.
- Wagner acquired 70,592 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
- He disposed of 35,777 shares of Class A Common Stock to cover tax obligations at a price of $7.84 per share.
- Following these transactions, Wagner directly owns 115,034 shares of Class A Common Stock and indirectly owns 182,900 shares through the Wagner Family Trust.
- He also directly owns 352,957 Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard executive compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for investor confidence and regulatory oversight.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock transactions.
- The transactions themselves are unlikely to have a significant impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| May 8, 2024 | Start date for monthly vesting of restricted stock unit award. |
| July 8, 2024 | Date of reported stock transactions. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.